GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pangen Biotech Inc (XKRX:222110) » Definitions » Cyclically Adjusted PB Ratio

Pangen Biotech (XKRX:222110) Cyclically Adjusted PB Ratio : 2.40 (As of Jun. 04, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Pangen Biotech Cyclically Adjusted PB Ratio?

As of today (2025-06-04), Pangen Biotech's current share price is ₩6320.00. Pangen Biotech's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was ₩2,635.10. Pangen Biotech's Cyclically Adjusted PB Ratio for today is 2.40.

The historical rank and industry rank for Pangen Biotech's Cyclically Adjusted PB Ratio or its related term are showing as below:

XKRX:222110' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.72   Med: 2.05   Max: 2.57
Current: 2.44

During the past years, Pangen Biotech's highest Cyclically Adjusted PB Ratio was 2.57. The lowest was 1.72. And the median was 2.05.

XKRX:222110's Cyclically Adjusted PB Ratio is ranked worse than
63.65% of 674 companies
in the Biotechnology industry
Industry Median: 1.475 vs XKRX:222110: 2.44

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Pangen Biotech's adjusted book value per share data for the three months ended in Mar. 2025 was ₩2,029.997. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₩2,635.10 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Pangen Biotech Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Pangen Biotech's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pangen Biotech Cyclically Adjusted PB Ratio Chart

Pangen Biotech Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 2.18

Pangen Biotech Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 1.57 2.18 1.76

Competitive Comparison of Pangen Biotech's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Pangen Biotech's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pangen Biotech's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pangen Biotech's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Pangen Biotech's Cyclically Adjusted PB Ratio falls into.


;
;

Pangen Biotech Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Pangen Biotech's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=6320.00/2635.10
=2.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pangen Biotech's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Pangen Biotech's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=2029.997/122.5900*122.5900
=2,029.997

Current CPI (Mar. 2025) = 122.5900.

Pangen Biotech Quarterly Data

Book Value per Share CPI Adj_Book
201506 0.000 100.051 0.000
201509 1,128.896 100.111 1,382.382
201512 1,096.769 100.220 1,341.572
201603 4,334.710 100.561 5,284.281
201606 4,211.516 100.791 5,122.395
201609 3,995.743 101.461 4,827.837
201612 3,901.705 101.561 4,709.570
201703 3,813.565 102.851 4,545.476
201706 3,730.251 102.611 4,456.541
201709 3,711.339 103.491 4,396.278
201712 3,255.954 102.991 3,875.564
201803 3,130.644 104.101 3,686.673
201806 3,144.906 104.130 3,702.419
201809 3,135.632 105.651 3,638.384
201812 2,794.109 104.351 3,282.487
201903 2,625.671 104.491 3,080.469
201906 2,472.725 104.881 2,890.244
201909 2,293.939 105.200 2,673.129
201912 1,911.054 105.121 2,228.626
202003 1,787.140 105.354 2,079.514
202006 1,714.057 105.112 1,999.074
202009 1,557.379 106.198 1,797.772
202012 1,473.881 105.765 1,708.338
202103 1,263.611 107.357 1,442.903
202106 2,081.871 107.579 2,372.373
202109 2,048.266 108.759 2,308.742
202112 1,976.937 109.676 2,209.707
202203 1,900.074 111.848 2,082.559
202206 1,698.853 114.072 1,825.705
202209 1,611.345 114.715 1,721.957
202212 1,612.612 115.179 1,716.370
202303 1,492.686 116.507 1,570.616
202306 1,479.113 117.182 1,547.373
202309 1,385.771 118.964 1,428.014
202312 1,176.810 118.837 1,213.974
202403 1,456.873 120.123 1,486.791
202406 1,474.438 120.007 1,506.170
202409 1,578.539 120.861 1,601.118
202412 1,971.718 121.135 1,995.398
202503 2,029.997 122.590 2,029.997

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Pangen Biotech  (XKRX:222110) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Pangen Biotech Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Pangen Biotech's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pangen Biotech Business Description

Traded in Other Exchanges
N/A
Address
4Floor Innoplex 2-dong, 306 Sinwon-ro, Yeongtong-gu, Gyeonggi-do, Suwon-si, KOR, 16675
Pangen Biotech Inc is a biotechnology company. It is engaged in development of biosimilar products and technology transfer services for biologics development. It develops biosimilar products, such as EPO, recombinant factor VIII, G-CSF, etc.

Pangen Biotech Headlines

No Headlines